Alnylam Pharmaceuticals (ALNY) Cash from Operations (2009 - 2026)

Alnylam Pharmaceuticals (ALNY) posted Cash from Operations of 70504000.0 for Q1 2026, down 56.89% on a QoQ basis from 163555000.0 in Q4 2025, and up 158.6% year-over-year from 27263625.41 in Q1 2025.

Alnylam Pharmaceuticals (ALNY) Cash from Operations (2009 - 2026) Analysis & Trends

Alnylam Pharmaceuticals' Cash from Operations history runs 18 years deep, the most recent figure standing at 70504000.0 for Q1 2026.

  • Quarterly Cash from Operations rose 158.6% year-over-year to 70504000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 714896000.0 (up 1617.54% YoY) and the FY2025 annual result came in at 524080000.0, up 6405.1% from the prior year.
  • Cash from Operations was 70504000.0 for Q1 2026 at Alnylam Pharmaceuticals, down from 163555000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 359412000.0 in Q3 2023 and bottomed at 171193000.0 in Q1 2022.
  • A 5-year average of 8773764.71 and a median of 58986000.0 in 2023 frame the typical range for Cash from Operations.
  • Annual changes were most pronounced in 2024 — Cash from Operations sank 217.71% — and 2025, when it surged 643.84%.
  • Alnylam Pharmaceuticals' Cash from Operations stood at 131978000.0 in 2022, then surged by 77.42% to 29795000.0 in 2023, then sank by 217.71% to 94662000.0 in 2024, then soared by 272.78% to 163555000.0 in 2025, then tumbled by 56.89% to 70504000.0 in 2026.
  • Business Quant data shows ALNY's Cash from Operations at 70504000.0 in Q1 2026, 163555000.0 in Q4 2025, and 325109000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -19.59 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -2.49 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 201.34 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.43 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.08 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -354.17 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 70.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 70.50 Mn
Mar 31, 2026 70.50 Mn
Dec 31, 2025 163.56 Mn
Dec 31, 2025 163.56 Mn
Sep 30, 2025 325.11 Mn
Sep 30, 2025 325.11 Mn
Jun 30, 2025 155.73 Mn
Jun 30, 2025 155.73 Mn
Mar 31, 2025 -120.31 Mn
Mar 31, 2025 -120.31 Mn
Dec 31, 2024 -94.66 Mn
Dec 31, 2024 -94.66 Mn
Sep 30, 2024 43.71 Mn
Sep 30, 2024 43.71 Mn
Jun 30, 2024 124.16 Mn
Jun 30, 2024 124.16 Mn
Mar 31, 2024 -81.52 Mn
Mar 31, 2024 -81.52 Mn
Dec 31, 2023 -29.80 Mn
Dec 31, 2023 -29.80 Mn